QuEChERS Extraction and Simultaneous Quantification in GC-MS/MS of Hexahydrocannabinol Epimers and Their Metabolites in Whole Blood, Urine, and Oral Fluid

Recently, hexahydrocannabinol (HHC) was posed under strict control in Europe due to the increasing HHC-containing material seizures. The lack of analytical methods in clinical laboratories to detect HHC and its metabolites in biological matrices may result in related intoxication underreporting. We...

Full description

Saved in:
Bibliographic Details
Published inMolecules (Basel, Switzerland) Vol. 29; no. 14; p. 3440
Main Authors Di Trana, Annagiulia, Sprega, Giorgia, Kobidze, Giorgi, Taoussi, Omayema, Lo Faro, Alfredo Fabrizio, Bambagiotti, Giulia, Montanari, Eva, Fede, Maria Sofia, Carlier, Jeremy, Tini, Anastasio, Busardò, Francesco Paolo, Di Giorgi, Alessandro, Pichini, Simona
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 22.07.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Recently, hexahydrocannabinol (HHC) was posed under strict control in Europe due to the increasing HHC-containing material seizures. The lack of analytical methods in clinical laboratories to detect HHC and its metabolites in biological matrices may result in related intoxication underreporting. We developed and validated a comprehensive GC-MS/MS method to quantify 9(R)-HHC, 9(S)-HHC, 9αOH-HHC, 9βOH-HHC, 8(R)OH-9(R)-HHC, 8(S)OH-9(S)HHC, 11OH-9(R)HHC, 11OH-9(S)HHC, 11nor-carboxy-9(R)-HHC, and 11nor-carboxy-9(S)-HHC in whole blood, urine, and oral fluid. A novel QuEChERS extraction protocol was optimized selecting the best extraction conditions suitable for all the three matrices. Urine and blood were incubated with β-glucuronidase at 60 °C for 2 h. QuEChERS extraction was developed assessing different ratios of Na2SO4:NaCl (4:1, 2:1, 1:1, w/w) to be added to 200 µL of any matrix added with acetonitrile. The chromatographic separation was achieved on a 7890B GC with an HP-5ms column, (30 m, 0.25 mm × 0.25 µm) in 12.50 min. The analytes were detected with a triple-quadrupole mass spectrometer in the MRM mode. The method was fully validated following OSAC guidelines. The method showed good validation parameters in all the matrices. The method was applied to ten real samples of whole blood (n = 4), urine (n = 3), and oral fluid (n = 3). 9(R)-HHC was the prevalent epimer in all the samples (9(R)/9(S) = 2.26). As reported, hydroxylated metabolites are proposed as urinary biomarkers, while carboxylated metabolites are hematic biomarkers. Furthermore, 8(R)OH-9(R)HHC was confirmed as the most abundant metabolite in all urine samples.
AbstractList Recently, hexahydrocannabinol (HHC) was posed under strict control in Europe due to the increasing HHC-containing material seizures. The lack of analytical methods in clinical laboratories to detect HHC and its metabolites in biological matrices may result in related intoxication underreporting. We developed and validated a comprehensive GC-MS/MS method to quantify 9(R)-HHC, 9(S)-HHC, 9αOH-HHC, 9βOH-HHC, 8(R)OH-9(R)-HHC, 8(S)OH-9(S)HHC, 11OH-9(R)HHC, 11OH-9(S)HHC, 11nor-carboxy-9(R)-HHC, and 11nor-carboxy-9(S)-HHC in whole blood, urine, and oral fluid. A novel QuEChERS extraction protocol was optimized selecting the best extraction conditions suitable for all the three matrices. Urine and blood were incubated with β-glucuronidase at 60 °C for 2 h. QuEChERS extraction was developed assessing different ratios of Na2SO4:NaCl (4:1, 2:1, 1:1, w/w) to be added to 200 µL of any matrix added with acetonitrile. The chromatographic separation was achieved on a 7890B GC with an HP-5ms column, (30 m, 0.25 mm × 0.25 µm) in 12.50 min. The analytes were detected with a triple-quadrupole mass spectrometer in the MRM mode. The method was fully validated following OSAC guidelines. The method showed good validation parameters in all the matrices. The method was applied to ten real samples of whole blood (n = 4), urine (n = 3), and oral fluid (n = 3). 9(R)-HHC was the prevalent epimer in all the samples (9(R)/9(S) = 2.26). As reported, hydroxylated metabolites are proposed as urinary biomarkers, while carboxylated metabolites are hematic biomarkers. Furthermore, 8(R)OH-9(R)HHC was confirmed as the most abundant metabolite in all urine samples.
Recently, hexahydrocannabinol (HHC) was posed under strict control in Europe due to the increasing HHC-containing material seizures. The lack of analytical methods in clinical laboratories to detect HHC and its metabolites in biological matrices may result in related intoxication underreporting. We developed and validated a comprehensive GC-MS/MS method to quantify 9(R)-HHC, 9(S)-HHC, 9αOH-HHC, 9βOH-HHC, 8(R)OH-9(R)-HHC, 8(S)OH-9(S)HHC, 11OH-9(R)HHC, 11OH-9(S)HHC, 11nor-carboxy-9(R)-HHC, and 11nor-carboxy-9(S)-HHC in whole blood, urine, and oral fluid. A novel QuEChERS extraction protocol was optimized selecting the best extraction conditions suitable for all the three matrices. Urine and blood were incubated with β-glucuronidase at 60 °C for 2 h. QuEChERS extraction was developed assessing different ratios of Na SO :NaCl (4:1, 2:1, 1:1, / ) to be added to 200 µL of any matrix added with acetonitrile. The chromatographic separation was achieved on a 7890B GC with an HP-5ms column, (30 m, 0.25 mm × 0.25 µm) in 12.50 min. The analytes were detected with a triple-quadrupole mass spectrometer in the MRM mode. The method was fully validated following OSAC guidelines. The method showed good validation parameters in all the matrices. The method was applied to ten real samples of whole blood (n = 4), urine (n = 3), and oral fluid (n = 3). 9(R)-HHC was the prevalent epimer in all the samples (9(R)/9(S) = 2.26). As reported, hydroxylated metabolites are proposed as urinary biomarkers, while carboxylated metabolites are hematic biomarkers. Furthermore, 8(R)OH-9(R)HHC was confirmed as the most abundant metabolite in all urine samples.
Recently, hexahydrocannabinol (HHC) was posed under strict control in Europe due to the increasing HHC-containing material seizures. The lack of analytical methods in clinical laboratories to detect HHC and its metabolites in biological matrices may result in related intoxication underreporting. We developed and validated a comprehensive GC-MS/MS method to quantify 9(R)-HHC, 9(S)-HHC, 9αOH-HHC, 9βOH-HHC, 8(R)OH-9(R)-HHC, 8(S)OH-9(S)HHC, 11OH-9(R)HHC, 11OH-9(S)HHC, 11nor-carboxy-9(R)-HHC, and 11nor-carboxy-9(S)-HHC in whole blood, urine, and oral fluid. A novel QuEChERS extraction protocol was optimized selecting the best extraction conditions suitable for all the three matrices. Urine and blood were incubated with β-glucuronidase at 60 °C for 2 h. QuEChERS extraction was developed assessing different ratios of Na2SO4:NaCl (4:1, 2:1, 1:1, w/w) to be added to 200 µL of any matrix added with acetonitrile. The chromatographic separation was achieved on a 7890B GC with an HP-5ms column, (30 m, 0.25 mm × 0.25 µm) in 12.50 min. The analytes were detected with a triple-quadrupole mass spectrometer in the MRM mode. The method was fully validated following OSAC guidelines. The method showed good validation parameters in all the matrices. The method was applied to ten real samples of whole blood (n = 4), urine (n = 3), and oral fluid (n = 3). 9(R)-HHC was the prevalent epimer in all the samples (9(R)/9(S) = 2.26). As reported, hydroxylated metabolites are proposed as urinary biomarkers, while carboxylated metabolites are hematic biomarkers. Furthermore, 8(R)OH-9(R)HHC was confirmed as the most abundant metabolite in all urine samples.Recently, hexahydrocannabinol (HHC) was posed under strict control in Europe due to the increasing HHC-containing material seizures. The lack of analytical methods in clinical laboratories to detect HHC and its metabolites in biological matrices may result in related intoxication underreporting. We developed and validated a comprehensive GC-MS/MS method to quantify 9(R)-HHC, 9(S)-HHC, 9αOH-HHC, 9βOH-HHC, 8(R)OH-9(R)-HHC, 8(S)OH-9(S)HHC, 11OH-9(R)HHC, 11OH-9(S)HHC, 11nor-carboxy-9(R)-HHC, and 11nor-carboxy-9(S)-HHC in whole blood, urine, and oral fluid. A novel QuEChERS extraction protocol was optimized selecting the best extraction conditions suitable for all the three matrices. Urine and blood were incubated with β-glucuronidase at 60 °C for 2 h. QuEChERS extraction was developed assessing different ratios of Na2SO4:NaCl (4:1, 2:1, 1:1, w/w) to be added to 200 µL of any matrix added with acetonitrile. The chromatographic separation was achieved on a 7890B GC with an HP-5ms column, (30 m, 0.25 mm × 0.25 µm) in 12.50 min. The analytes were detected with a triple-quadrupole mass spectrometer in the MRM mode. The method was fully validated following OSAC guidelines. The method showed good validation parameters in all the matrices. The method was applied to ten real samples of whole blood (n = 4), urine (n = 3), and oral fluid (n = 3). 9(R)-HHC was the prevalent epimer in all the samples (9(R)/9(S) = 2.26). As reported, hydroxylated metabolites are proposed as urinary biomarkers, while carboxylated metabolites are hematic biomarkers. Furthermore, 8(R)OH-9(R)HHC was confirmed as the most abundant metabolite in all urine samples.
Author Pichini, Simona
Tini, Anastasio
Taoussi, Omayema
Sprega, Giorgia
Carlier, Jeremy
Di Trana, Annagiulia
Montanari, Eva
Lo Faro, Alfredo Fabrizio
Kobidze, Giorgi
Bambagiotti, Giulia
Fede, Maria Sofia
Di Giorgi, Alessandro
Busardò, Francesco Paolo
Author_xml – sequence: 1
  givenname: Annagiulia
  surname: Di Trana
  fullname: Di Trana, Annagiulia
– sequence: 2
  givenname: Giorgia
  surname: Sprega
  fullname: Sprega, Giorgia
– sequence: 3
  givenname: Giorgi
  surname: Kobidze
  fullname: Kobidze, Giorgi
– sequence: 4
  givenname: Omayema
  orcidid: 0009-0008-0633-2117
  surname: Taoussi
  fullname: Taoussi, Omayema
– sequence: 5
  givenname: Alfredo Fabrizio
  orcidid: 0000-0002-0240-5277
  surname: Lo Faro
  fullname: Lo Faro, Alfredo Fabrizio
– sequence: 6
  givenname: Giulia
  surname: Bambagiotti
  fullname: Bambagiotti, Giulia
– sequence: 7
  givenname: Eva
  orcidid: 0000-0003-0044-1714
  surname: Montanari
  fullname: Montanari, Eva
– sequence: 8
  givenname: Maria Sofia
  surname: Fede
  fullname: Fede, Maria Sofia
– sequence: 9
  givenname: Jeremy
  orcidid: 0000-0003-3332-9518
  surname: Carlier
  fullname: Carlier, Jeremy
– sequence: 10
  givenname: Anastasio
  surname: Tini
  fullname: Tini, Anastasio
– sequence: 11
  givenname: Francesco Paolo
  surname: Busardò
  fullname: Busardò, Francesco Paolo
– sequence: 12
  givenname: Alessandro
  orcidid: 0000-0003-2997-221X
  surname: Di Giorgi
  fullname: Di Giorgi, Alessandro
– sequence: 13
  givenname: Simona
  surname: Pichini
  fullname: Pichini, Simona
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39065018$$D View this record in MEDLINE/PubMed
BookMark eNp1ksluFDEQhlsoiCzwAFyQJS4cMsRuu7cjjCaLlFEUJhFHy0uZ8chtD3a3lLwKT4unJ0EoiJNL9vf_VeWq4-LABw9F8Z7gz5R2-KwPDtToIJUdYZQx_Ko4IqzEM4pZd_BXfFgcp7TBuCSMVG-KwyyuK0zao-LX7biYrxffVmjxMEShBhs8El6jle1HNwgPYUzodhR-sMYqMb1bjy7ms-XqbLlCwaBLeBDrRx2DEt4LaX1waLG1PcQ0Wd2twUa0hEHI4OwAaWfwfZ2LR19dCPoU3Ufr4XSCb6Jw6NyNVr8tXhvhErx7Ok-K-_PF3fxydn1zcTX_cj1TjLbDrMaCCSGF1syQWopS0dyZajtDcru0kkySHDcGdKuaGqTBBrq2BKmhqpuanhRXe18dxIZvo-1FfORBWD5dhPiDizhY5YC3sqo7JRpjGsw0NrLTdc4FSkLZ0LrJXp_2XtsYfo6QBt7bpMC5_Udyitsql0XJLu3HF-gmjNHnTncU61rcdTRTH56oUfag_5T3PMEMNHtAxZBSBMOVHaYx5XFaxwnmu13h_-xKVpIXymfz_2t-AxGVxQQ
CitedBy_id crossref_primary_10_33003_fjs_2024_0806_2957
crossref_primary_10_1038_s41598_025_93931_4
Cites_doi 10.1007/978-1-0716-2605-4_7
10.1002/dta.3403
10.1002/dta.3595
10.1002/jms.4436
10.1007/s00216-013-7419-7
10.1007/s00769-002-0487-6
10.1007/s11419-021-00600-y
10.1002/dta.3038
10.1016/j.jpba.2023.115918
10.1021/ac020361s
10.2174/1570159X21666230623104624
10.1111/jnu.12817
10.1093/jat/bkad079
10.3390/ph17020249
10.1177/14690667231200139
10.1080/17425255.2023.2252324
10.1016/j.jpba.2022.114987
10.1021/acschemneuro.9b00586
10.1002/dta.3610
10.3389/fchem.2019.00109
ContentType Journal Article
Copyright 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOA
DOI 10.3390/molecules29143440
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DOAJ - Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef
PubMed

MEDLINE - Academic
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1420-3049
ExternalDocumentID oai_doaj_org_article_8b569ca7ff704d0fb9d618cecbe27367
39065018
10_3390_molecules29143440
Genre Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GroupedDBID ---
0R~
123
2WC
53G
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABUWG
ACGFO
ACIWK
ACPRK
ACUHS
AEGXH
AENEX
AFKRA
AFPKN
AFRAH
AFZYC
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D1I
DIK
DU5
E3Z
EBD
EMOBN
ESX
FYUFA
GROUPED_DOAJ
GX1
HH5
HMCUK
HYE
HZ~
I09
IAO
IHR
ITC
KQ8
LK8
M1P
MODMG
O-U
O9-
OK1
P2P
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RPM
SV3
TR2
TUS
UKHRP
~8M
NPM
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
PUEGO
ID FETCH-LOGICAL-c438t-60a4aabadd4f16ba2c3018c89f121435b4b19f17fed8c76ebf0fe982ebde56763
IEDL.DBID 7X7
ISSN 1420-3049
IngestDate Wed Aug 27 01:28:48 EDT 2025
Thu Jul 10 16:45:13 EDT 2025
Sat Jul 26 02:59:43 EDT 2025
Thu Apr 03 07:04:17 EDT 2025
Tue Jul 01 03:59:56 EDT 2025
Thu Apr 24 22:53:55 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 14
Keywords cannabinoids
hexahydrocannabinol epimers
GC-MS/MS
new psychoactive substances
QuEChERS
hexahydrocannabinol metabolites
Language English
License https://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c438t-60a4aabadd4f16ba2c3018c89f121435b4b19f17fed8c76ebf0fe982ebde56763
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-0240-5277
0009-0008-0633-2117
0000-0003-3332-9518
0000-0003-2997-221X
0000-0003-0044-1714
OpenAccessLink https://www.proquest.com/docview/3084980993?pq-origsite=%requestingapplication%
PMID 39065018
PQID 3084980993
PQPubID 2032355
ParticipantIDs doaj_primary_oai_doaj_org_article_8b569ca7ff704d0fb9d618cecbe27367
proquest_miscellaneous_3085121316
proquest_journals_3084980993
pubmed_primary_39065018
crossref_citationtrail_10_3390_molecules29143440
crossref_primary_10_3390_molecules29143440
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-Jul-22
PublicationDateYYYYMMDD 2024-07-22
PublicationDate_xml – month: 07
  year: 2024
  text: 2024-Jul-22
  day: 22
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Molecules (Basel, Switzerland)
PublicationTitleAlternate Molecules
PublicationYear 2024
Publisher MDPI AG
Publisher_xml – name: MDPI AG
References Derne (ref_13) 2023; 16
Peters (ref_18) 2023; 19
(ref_7) 2023; 5
ref_14
Elskens (ref_23) 2002; 7
Schirmer (ref_10) 2023; 29
ref_12
ref_21
ref_20
Pulver (ref_3) 2023; 15
Haschimi (ref_4) 2021; 13
ref_1
ref_19
ref_15
Ifa (ref_17) 2019; 54
ref_9
Worob (ref_2) 2019; 11
Matuszewski (ref_24) 2003; 75
Meyer (ref_22) 2013; 405
Graziano (ref_8) 2023; 21
Manier (ref_11) 2023; 47
Suriaga (ref_5) 2023; 55
ref_6
Caldas (ref_16) 2022; 40
References_xml – ident: ref_19
  doi: 10.1007/978-1-0716-2605-4_7
– ident: ref_9
– volume: 15
  start-page: 255
  year: 2023
  ident: ref_3
  article-title: EMCDDA Framework and Practical Guidance for Naming Synthetic Cannabinoids
  publication-title: Drug Test. Anal.
  doi: 10.1002/dta.3403
– volume: 16
  start-page: 638
  year: 2023
  ident: ref_13
  article-title: Immunological Detection of Hexahydrocannabinol (HHC) in Oral Fluid
  publication-title: Drug Test. Anal.
  doi: 10.1002/dta.3595
– volume: 54
  start-page: 834
  year: 2019
  ident: ref_17
  article-title: Analysis of Tetrahydrocannabinol Derivative from Cannabis-Infused Chocolate by QuEChERS-Thin Layer Chromatography-Desorption Electrospray Ionization Mass Spectrometry
  publication-title: J. Mass Spectrom.
  doi: 10.1002/jms.4436
– volume: 405
  start-page: 9779
  year: 2013
  ident: ref_22
  article-title: Qualitative Metabolism Assessment and Toxicological Detection of Xylazine, a Veterinary Tranquilizer and Drug of Abuse, in Rat and Human Urine Using GC-MS, LC-MS n, and LC-HR-MS n
  publication-title: Anal. Bioanal. Chem.
  doi: 10.1007/s00216-013-7419-7
– volume: 7
  start-page: 281
  year: 2002
  ident: ref_23
  article-title: Linearity of Calibration Curves: Use and Misuse of the Correlation Coefficient
  publication-title: Accredit. Qual. Assur.
  doi: 10.1007/s00769-002-0487-6
– volume: 40
  start-page: 88
  year: 2022
  ident: ref_16
  article-title: Determination of New Psychoactive Substances and Other Drugs in Postmortem Blood and Urine by UHPLC–MS/MS: Method Validation and Analysis of Forensic Samples
  publication-title: Forensic. Toxicol.
  doi: 10.1007/s11419-021-00600-y
– volume: 13
  start-page: 1499
  year: 2021
  ident: ref_4
  article-title: New Synthetic Cannabinoids Carrying a Cyclobutyl Methyl Side Chain: Human Phase I Metabolism and Data on Human Cannabinoid Receptor 1 Binding and Activation of Cumyl-CBMICA and Cumyl-CBMINACA
  publication-title: Drug Test. Anal.
  doi: 10.1002/dta.3038
– volume: 5
  start-page: 165
  year: 2023
  ident: ref_7
  article-title: Hexahydrocannabinol: Review of the Chemistry and Pharmacology of an Understudied Cannabinoid
  publication-title: Med. Cannabis Cannabinoids
– ident: ref_12
  doi: 10.1016/j.jpba.2023.115918
– volume: 75
  start-page: 3019
  year: 2003
  ident: ref_24
  article-title: Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC-MS/MS
  publication-title: Anal. Chem.
  doi: 10.1021/ac020361s
– volume: 21
  start-page: 2424
  year: 2023
  ident: ref_8
  article-title: Hexahydrocannabinol Pharmacology, Toxicology, and Analysis: The First Evidence for a Recent New Psychoactive Substance
  publication-title: Curr. Neuropharmacol.
  doi: 10.2174/1570159X21666230623104624
– volume: 55
  start-page: 623
  year: 2023
  ident: ref_5
  article-title: Cannabinoids and Synthetic Cannabinoids as a Cause of Death: Trends and Their Healthcare Implications
  publication-title: J. Nurs. Scholarsh.
  doi: 10.1111/jnu.12817
– ident: ref_1
– volume: 47
  start-page: 818
  year: 2023
  ident: ref_11
  article-title: Analytical Toxicology of the Semi-Synthetic Cannabinoid Hexahydrocannabinol Studied in Human Samples, Pooled Human Liver S9 Fraction, Rat Samples and Drug Products Using HPLC-HRMS-MS
  publication-title: J. Anal. Toxicol.
  doi: 10.1093/jat/bkad079
– ident: ref_21
  doi: 10.3390/ph17020249
– volume: 29
  start-page: 326
  year: 2023
  ident: ref_10
  article-title: Identification of Human Hexahydrocannabinol Metabolites in Urine
  publication-title: Eur. J. Mass Spectrom.
  doi: 10.1177/14690667231200139
– volume: 19
  start-page: 487
  year: 2023
  ident: ref_18
  article-title: Current State-of-the-Art Approaches for Mass Spectrometry in Clinical Toxicology: An Overview
  publication-title: Expert Opin. Drug Metab. Toxicol.
  doi: 10.1080/17425255.2023.2252324
– ident: ref_6
  doi: 10.1016/j.jpba.2022.114987
– ident: ref_20
– volume: 11
  start-page: 3881
  year: 2019
  ident: ref_2
  article-title: DARK Classics in Chemical Neuroscience: Synthetic Cannabinoids (Spice/K2)
  publication-title: ACS Chem. Neurosci.
  doi: 10.1021/acschemneuro.9b00586
– ident: ref_15
  doi: 10.1002/dta.3610
– ident: ref_14
  doi: 10.3389/fchem.2019.00109
SSID ssj0021415
Score 2.4301164
Snippet Recently, hexahydrocannabinol (HHC) was posed under strict control in Europe due to the increasing HHC-containing material seizures. The lack of analytical...
SourceID doaj
proquest
pubmed
crossref
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
StartPage 3440
SubjectTerms cannabinoids
Chromatography
GC-MS/MS
hexahydrocannabinol epimers
hexahydrocannabinol metabolites
Laboratories
Marijuana
Metabolism
Metabolites
Methods
new psychoactive substances
Psychotropic drugs
QuEChERS
Tetrahydrocannabinol
THC
Urine
SummonAdditionalLinks – databaseName: DOAJ - Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9swEBejL9vL2Pe8dUODPY2ayLYsS49rcBYG2ejSsL4ZfdJA6pTEge5f6V_bO8sJhbHtZW_GPotDd9LdSXe_I-SjsUyFSrJUYQoNh6AjNWCmUi89iBsMmu_R9mffxHTBv16UF_dafWFOWIQHjhM3kqYUyuoqhIpxx4JRTmTSems8WF7R15GDzdsHU0OolYFdineYBQT1o6vYatZvcwX-AceTjntWqAfr_7OH2VuayRPyeHAR6efI2lPywLfPyMPxvjPbc3J7tqvHl_WPOa1vuk2sTKC6dXS-xPxA3XoI5-nZTsdEoH7u6bKlX8bpbD6azek60Km_0Ze_HJgv3bYawuP1itbXSzzF7oc6xwsEOvMdKAmWKW9xgJ_YTJeeYq77CV1g3eBJT_x9A_xOVrule0EWk_p8PE2HHgup5YXsUsE019rALsdDJozOLax4aaUKWY6ulOEmg-cqeCdtJbwJLHglc2-cLwVsTi_JUbtu_WtCS2mNLhwIXwcuXKkKZVhgiEBouA0uIWw_540dAMixD8aqgUAExdT8JqaEfDr8ch3RN_5GfIqCPBAicHb_AtSpGdSp-Zc6JeR4rwbNsJq3TcEkVxJ86SIhHw6fQeh4uRKFijQlwuNlIiGvovocOAF2BQInvvkfHL4lj3JwrPB8Oc-PyVG32fl34Bh15n2_Bu4Aa1oOxQ
  priority: 102
  providerName: Directory of Open Access Journals
Title QuEChERS Extraction and Simultaneous Quantification in GC-MS/MS of Hexahydrocannabinol Epimers and Their Metabolites in Whole Blood, Urine, and Oral Fluid
URI https://www.ncbi.nlm.nih.gov/pubmed/39065018
https://www.proquest.com/docview/3084980993
https://www.proquest.com/docview/3085121316
https://doaj.org/article/8b569ca7ff704d0fb9d618cecbe27367
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9NAEF5Be4AL4o2hRIvECdXKxl6v1ydEIqcRUgptGpGbtU8aKdghcaTyV_i1zNhOioToJbLi8Wrtmd157jeEvNeGZT6VLMywhIaD0xFqUFOhkw7YDQrNNWj703MxmfPPi2TRBdy2XVnlfk9sNmpbGYyR92MmeSbBnok_rn-G2DUKs6tdC4375Bihy7CkK13cOlwD0E5tJjMG177_o20467ZRBlYCx3jHX7qogez_v53Z6JvxY_KoMxTpp5azT8g9Vz4lD0b7_mzPyO-LXT66zi9nNL-pN-35BKpKS2dLrBJUpQOnnl7sVFsO1HCALkt6Ngqns_50RitPJ-5GXf-yoMRUWSpwkqsVzddLjGU3Q11hGoFOXQ2igoeVtzjAN2ypS4dY8X5K53h68LQh_rKB-Y5Xu6V9Tubj_Go0CbtOC6HhsaxDwRRXSsNex_1AaBUZWPfSyMwPIjSoNNcDuE69s9KkwmnPvMtk5LR1iYAt6gU5KqvSvSI0kUar2IIIKM-FTbI408wzxCHU3HgbELb_5oXpYMixG8aqAHcE2VT8w6aAfDg8sm4xOO4iHiIjD4QIn938UW2-F91qLKRORGZU6n3KuGVeZ1bA-zqjHZhzIg3IyV4Mim5Nb4tbCQzIu8NtYDqmWFqmIk2CIHkDEZCXrfgcZgLTFQif-Pruwd-QhxEYThg_jqITclRvdu4tGD617jXSDb9yfNYjx8P8_Otlrwki_AHBCQjZ
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VcigXxJuUAosEF1Qrjr1e7x4QoiFpSpuikkTtzeyTRkrtkIdo_wo_gt_IjB0HJERvvUXxZrTO983OzO7sDCGvtQmlT0UYSEyhYRB0BBrMVOCEA7jBoLmy2n7_mPdG7NNZcrZBftV3YTCtsl4Ty4XaFgb3yJtxKJgU4M_E76ffA-wahaerdQuNihaH7uoHhGzzdwcfAd83UdTtDNu9YNVVIDAsFouAh4oppUGvmW9xrSIDHBdGSN-K0HnQTLfgc-qdFSblTvvQOykip61LOKgjyL1FbrM4lqhRoru_DvBaYA2rk1N4GDYvqga3bh5JEMxwf-Uv21e2CPi_X1vat-49cnflmNIPFZPukw2XPyBb7bof3EPy82TZaZ93vgxo53Ixq-5DUJVbOhhjVqLKXbGc05OlqtKPSsTpOKf77aA_aPYHtPC05y7V-ZUFo6nyXEFQXkxoZzrGvfNS1BCPLWjfLYCaeDl6jgJOsYUv3cMM-106wtuKu-XgzzOYb3eyHNtHZHQjGDwmm3mRu6eEJsJoFVugnPKM20TGUoc-xLqHmhlvGySs__PMrMqeY_eNSQbhD8KU_QNTg7xd_2Ra1fy4bvAeArkeiOW6yy-K2bdspf2Z0AmXRqXepyGzodfScnhfZ7QD95GnDbJT0yBbrSHz7A_jG-TV-jGAjkc6Fag4JsGifC3eIE8q-qxnAtPlWK5x-3rhL8lWb9g_yo4Ojg-fkTsROG24dx1FO2RzMVu65-B0LfSLkumUfL1p1foN3PRD6g
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELZKkaAXxJtAASPBBXUV78trHxCiaUJKSaGkEbktttduI4XdkIdo_wo_hV_HzD5SJERvvUUb78jJ941nxh7PEPJSGyZdIpgnMYUmgqDD02CmPCsswA0GzZbV9geHvD-KPozj8Qb53dyFwbTKZk0sF-qsMLhH3g6ZiKQAfyZsuzot4vNe7-3sh4cdpPCktWmnUVHkwJ7_hPBt8WZ_D7B-FQS97nGn79UdBjwThWLpcaYipTToeOR8rlVggO_CCOn8AB0JHWkfPifOZsIk3GrHnJUisDqzMQfVBLnXyPUkjH3UsWR8Eez5YBmrU9QwlKz9vWp2axeBBMER7rX8ZQfLdgH_93FLW9e7TW7VTip9V7HqDtmw-V1ys9P0hrtHfh2tup3T7pch7Z4t59XdCKryjA4nmKGoclusFvRopapUpBJ9Osnp-443GLYHQ1o42rdn6vQ8AwOq8lxBgF5MaXc2wX30UtQxHmHQgV0CTfGi9AIFfMV2vnQXs-136AhvLu6Ugz_NYb696WqS3SejK8HgAdnMi9w-IjQWRqswA_opF_EslqHUzDGsgagj47IWYc1_npq6BDp24pimEAohTOk_MLXI6_Urs6r-x2WDdxHI9UAs3V0-KOYnab0SpELHXBqVOJewKGNOy4zD77VGW3AledIi2w0N0no9WaQX7G-RF-uvAXQ83qlAxTExFujzeYs8rOiznglMl2PpxseXC39OboBSpR_3Dw-ekK0A_Dfcxg6CbbK5nK_sU_C_lvpZSXRKvl21Zv0BdKJIFw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=QuEChERS+Extraction+and+Simultaneous+Quantification+in+GC-MS%2FMS+of+Hexahydrocannabinol+Epimers+and+Their+Metabolites+in+Whole+Blood%2C+Urine%2C+and+Oral+Fluid&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Annagiulia+Di+Trana&rft.au=Sprega%2C+Giorgia&rft.au=Giorgi+Kobidze&rft.au=Taoussi%2C+Omayema&rft.date=2024-07-22&rft.pub=MDPI+AG&rft.eissn=1420-3049&rft.volume=29&rft.issue=14&rft.spage=3440&rft_id=info:doi/10.3390%2Fmolecules29143440&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon